Keywords: merck, co, stops, taranabant, ph, iii, drug

Merck & Co stops taranabant at Ph III

Article | 13 October 2008

Print This

US drug major Merck & Co has discontinued the development of taranabant, after the obesity drug showed disappointing efficacy in a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in